FAP protein as a marker for fibrotic lung disease
Part of Lungs & breathing clinical trials.
This trial is looking at a protein called FAP in the blood of people with fibrotic lung diseases. It aims to understand how this protein might be used as a marker to help doctors better diagnose and track these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a fibrotic lung disease, like idiopathic pulmonary fibrosis or another fibrotic interstitial lung disease.
- You cannot be pregnant or nursing.
- You must not have any other significant medical condition that could interfere with the study.
- You must not have an active lung cancer or any other active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new imaging method called FAPI-PET to see if it can help find and understand tumors better than standard scans. It is for people with newly diagnosed stomach/esophageal cancer, pancreatic cancer, or those with unclear symptoms or scan results.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This trial tests a new radioactive treatment (177Lu-OncoFAP-23) alone or combined with an immunotherapy (L19-IL2) for people with advanced solid tumors that have a specific protein called FAP. It's for patients whose cancer has grown despite standard therapies.
This study uses a special PET scan called 18F-FAPI-04 to take detailed images of different kinds of cancer. It aims to see if this scan can help doctors better find and monitor tumors.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.